Ensysce Biosciences Files 8-K: Material Agreement & Equity Sales
Ticker: ENSCW · Form: 8-K · Filed: Apr 24, 2025 · CIK: 1716947
| Field | Detail |
|---|---|
| Company | Ensysce Biosciences, INC. (ENSCW) |
| Form Type | 8-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-filing
Related Tickers: ENSY
TL;DR
Ensysce Bio (ENSY) filed an 8-K detailing a new material agreement and equity sales. Watch for updates.
AI Summary
Ensysce Biosciences, Inc. announced on April 23, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. The filing includes financial statements and exhibits.
Why It Matters
This 8-K filing indicates significant corporate activity, including a new material agreement and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and operational risks.
Key Players & Entities
- Ensysce Biosciences, Inc. (company) — Registrant
- Leisure Acquisition Corp. (company) — Former Company Name
- April 23, 2025 (date) — Date of earliest event reported
- April 24, 2025 (date) — Date of Report
FAQ
What is the nature of the material definitive agreement entered into by Ensysce Biosciences?
The filing states that Ensysce Biosciences, Inc. entered into a material definitive agreement on April 23, 2025, but the specific details of this agreement are not provided in the summary information.
What type of equity securities were sold by Ensysce Biosciences?
The filing mentions "Unregistered Sales of Equity Securities" as an item of disclosure, but the specific type and amount of securities are not detailed in the provided text.
What are the "Other Events" reported in this 8-K filing?
The filing lists "Other Events" as a category of information, but the specific events are not elaborated upon in the provided summary.
When was Ensysce Biosciences, Inc. formerly known as Leisure Acquisition Corp.?
Ensysce Biosciences, Inc. was formerly known as Leisure Acquisition Corp. prior to a name change on September 13, 2017.
What is the principal executive office address for Ensysce Biosciences, Inc.?
The principal executive offices of Ensysce Biosciences, Inc. are located at 7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding Ensysce Biosciences, Inc. (ENSCW).